The natural history of Moyamoya disease (MD) is variable. Moyamoya disease in children mostly presents with progressive ischemic complications and in adulthood it tends to present with hemorrhage. Surgical strategies depend on augmenting cerebral blood flow to the anterior cerebral circulation. Revascularization is the mainstay treatment for MD. We introduce a 31 year old female with a history of MD and leftsided revascularization as a child, who presented with headache, confusion, and worsening left sided weakness. Cranial computed tomography (CT) showed a right sided putaminal hemorrhage. Cerebral angiogram with selective external runs revealed MD, hypoplastic parietal branch of the superficial temporal artery (STA) on the right side and previous revascularization on the left side. Thus, our decision was made to perform a bypass with the frontal branch of the STA to an M3-M4 segment of the middle cerebral artery and an encephaloduroarteriomyosynangiosis with the parietal branch of the STA. The patient's postoperative course was uneventful. Postoperative CT angiogram confirmed patency of bypass. This technique provides immediate revascularization and seems to provide risk reduction for ischemic and hemorrhagic stroke. We review the natural history and surgical treatment of MD along with a case presentation in which surgical technique is demonstrated in video.
INTRODUCTION
Moyamoya disease (MD) is a progressive steno-occlusive disease of the circle of Willis. Primarily, MD results in gradual stenosis of bilateral supraclinoid internal carotid arteries and subsequent compensatory proliferative pial collateral formation. This consequential pial collateralization forms a characteristic "puff of smoke" appearance on digital subtraction angiography and thus the disease was coined after the Japanese term "Moyamoya" which means "puff of smoke". Though the purpose of proliferative perforators and anastomotic branches are to provide collateral blood supply to the hypoperfused territories of the circle of Willis, these fragile vessels commonly occlude or leak resulting in both ischemic and hemorrhagic strokes (4) .
There are many ways to categorize the severity of MD. The modified Suzuki classification defines MD severity based on the development of extensive collateral networks at the base of the brain and from the external carotid artery (26) . This is
Li Y. et al: Treatment of Moyamoya Disease with STA-MCA Bypass and EDAS
the most widely used classification system and correlates with diminished cortical perfusion from the anterior circulation.
Because the etiology of MD is unknown, the traditional management of MD has been focused on prevention of hemorrhage and stroke by augmenting cerebral blood flow. The literature suggests that in addition to antiplatelet medications, both direct and indirect surgical revascularization techniques are effective in reducing the risk of ischemia and hemorrhage (5, 7, 18, 24) . In this article, we review the natural history and surgical treatment of MD along with a case presentation in which surgical technique is demonstrated in video.
CASE ILLUSTRATION WITH VIDEO PRESENTATION
We introduce the case of a 31 year old female who presented with a history of MD and left-sided revascularization as a child. She also presented with headache, confusion, and worsening left sided weakness. Computed Tomography scan (CT) showed a right sided putaminal hemorrhage (Figure 1 ). Cerebral angiogram revealed supraclinoid internal carotid artery stenosis with a proliferative pial collateralization from the external carotid artery and posterior circulation consistent with MD (Figure 2 A,B ).
Cerebral angiogram with selective external runs also revealed that the parietal branch of the STA was hypoplastic ( Figure  3) . Thus, the decision was made to perform a bypass with the frontal branch of the superficial temporal artery (STA) to an M3-M4 segment of the middle cerebral artery (MCA) and an encephaloduroarteriomyosynangiosis (EDAS) with the parietal branch of the STA.
In such a procedure, the patient is placed in the supine position with the head turned to the contralateral side 20-30 degrees and slightly extended. An incision is marked directly over the STA branches mapped out by Doppler sonography. Dissection of the STA is performed under microscopic magnification and illumination. The scalp is retracted using fine fish-hooks and exposure of the artery is carried out using a combination of sharp and blunt dissection techniques.
First the main trunk of the STA, then the frontal and parietal branches of the STA are identified. The incision is extended posteriorly over the parietal branch to expose an appropriate length of STA for the EDAS procedure. The side branches of the parietal STA are cauterized and the artery is mobilized with a cuff of tissue from the galeal layer. The parietal STA is covered by nitroprusside soaked gelfoam and telfa patties and the dissection is now turned towards the frontal branch of the STA. The frontal branch of the STA is harvested in the same manner, again making sure there is adequate length for the bypass.
Next the temporalis muscle is divided, dissected, and retracted away from the underlying bone. A pterional craniotomy is created to expose the distal branches of the MCA emanating from the sylvian fissure. The dura is opened and the cortex is inspected for a suitable recipient M4 branch. Ideal recipients are free from side branches and easily dissectible from the arachnoid.
Once the donor and recipient vessels are dissected free, the donor vessel is clipped with a temporary aneurysm clip, irrigated with heparinized saline, and placed on a telfa patty. Adventisectomy is performed in the distal end of the STA. The temporary clip is released periodically to prevent any intraluminal clot formation.
After preparing the recipient vessel, the frontal STA is irrigated with nitroprusside solution to prevent vasospasm. Next the donor artery is marked with blue dye, divided at an angle, and fish mouthed in order to prepare it for anastomosis. A 10-0 nylon suture on a non-cutting needle is placed through the apex of the donor vessel prior to clamping the recipient artery to facilitate anastomosis. Once the arteriotomy length is measured and the recipient branch is marked with blue dye and temporary clips are placed to interrupt blood flow for anastomosis, the small arteriotomy is performed using an ophthalmic knife and extended using micro-scissors. Next the heel of the donor is sutured to the end of the donor vessel to approximate the end to side anastomosis. The sutures are placed in an interrupted fashion. Upon completion of the anastomosis, the temporary clips are removed and hemostasis from the suture site is obtained with application of Surgicel. Both Indocyanine Green and micro-Doppler ultrasonography are used to confirm patency of the bypass.
Upon completion of the STA-MCA bypass, the pia/arachnoid over the cerebral cortex is opened and the proximal end of the frontal branch of STA is sutured with 10-0 nylon onto the arachnoid membrane. This allows for synangiosis between the donor STA and the cerebral cortex. This technique allows for concomitant STA-MCA bypass and EDAS procedures to be performed.
The parietal STA is similarly anchored to the arachnoid of the cerebral cortex after the underlying pia/arachnoid membranes have been opened. This technique stabilizes the graft and stimulates synangiosis.
Prior to closure, hemostasis is obtained using Surgicel and gelfoam patties. It is important to close the dura loosely as well as rongeur the craniotomy flap to prevent compression of the graft during closure. Post-operatively the patient should be started on an aspirin daily, blood pressure should be kept on the higher side of normal, and the graft site should be kept void of compression to prevent any chances of graft occlusion.
The patient's postoperative course was uneventful. Postoperative CT angiogram confirmed patency of bypass ( Figure  4A , B).
DISCUSSION
The natural history of MD is extremely variable between patients. Depending on the etiology, MD may be slowly progressive with intermittent, rare, or no neurologic sequelae. In others the disease may progress rapidly with frequent and swift neurologic decline. Despite the robust variability of symptoms amongst patients, Moyamoya is inevitably progressive in a great majority of the affected population with a 73% rate of major deficit or death in children followed two years after diagnosis (19) .
In general MD in children presents with progressive ischemic complications and up to two-thirds of cases will develop either ischemic or hemorrhagic complications if left untreated over a five-year period (22, 23) . MD presenting in adulthood is less likely to be ischemic or as progressive as in the pediatric population but despite maximal medical therapy, over 20% of adult patients will also experience symptomatic progression. In adults, although there is a higher probability of experiencing hemorrhagic complications, gradual hypoperfusion can result in significant impairment in learning and memory as well (28) . The cumulative ischemic effects on adults warrants aggressive intervention targeting both the ischemic and hemorrhagic complications of MD.
In patients who have had a previous ischemic or hemorrhagic event, Hallemeier et al. found a 65% risk of recurrent ipsilateral stroke at 5 years with medical therapy alone (7). The outcome is even worse in patients without medical or surgical treatment (3, 14) . With surgical revascularization however, a recent meta-analysis estimated rates of symptomatic progression in these patients to be 2.6% after surgery (5). Several studies have followed patients with "asymptomatic" MD, which is to say patients without history of ischemic or hemorrhagic strokes and found an annual stroke risk of about 3% per year (7,12,29). Surgical intervention in patients presenting with a previous ischemic or hemorrhagic event appears to reduce the risk more towards that of the natural history of asymptomatic patients. Surgical revascularization may also improve the impairments in cognition and memory in adults with MD (28) . Generally speaking, regardless of ancestry, age, or Suzuki grade, asymptomatic patients have improved long term outcomes suggesting that prompt diagnosis and early institution of preventative treatment modalities may be the most beneficial treatment strategy (22) .
The cause of MD is unknown and thus mechanism specific prevention and reversal drug therapies are currently unavailable. The mainstay of medical management is based on the anti-platelet properties of Aspirin which prevents the ischemic complications of MD (2). The contemporary treatment strategy relies on both medical therapy and surgical revascularization (8, 15) .
Surgical strategies depend on augmenting cerebral blood flow to the anterior cerebral circulation. Revascularization is the mainstay treatment for MD. Revascularization typically falls into two broad categories; indirect revascularization and direct revascularization. Hybrid procedures with combined direct and indirect bypasses have also been reported with good results (4,13,27).
Indirect bypass procedures such as encephaloduroarteriomyosynangiosis and encephaloduroarteriorsynangiosis have been shown to resolve symptoms in a high proportion of patients (20) . Direct bypass procedures such as STA to MCA bypass have also been equally effective. Some neurosurgeons favor one procedure over another while others use a combination of these techniques (11). Although there is evidence that support both indirect and direct revascularization techniques, unfortunately there is no Class I data comparing or recommending the use of one technique over another and thus the best strategy remains controversial. The authors also found a 1.9% re-hemorrhage rate at two year follow-up; however, patients presenting with post-operative ipsilateral re-hemorrhage had a mortality of 80 (10). Other series also support a high mortality rate in patients suffering postrevascularization hemorrhage in upwards of 50% (16) . Despite high mortality rates from post-operative hemorrhages, overall, direct revascularization carries a high likelihood of good outcomes in patients with hemorrhagic MD. Direct bypass has been hypothesized to reduce the hemodynamic stress on fragile collateral vessels thus preventing recurrent hemorrhage; however, it is rational that post-procedural hemorrhages are more severe due to the increased cerebral perfusion (21).
There is variability regarding which form of revascularization is preferred. Most authors' preferred technique, whether direct, indirect, or combined, reflect their comfort level, training bias, and the patient specific anatomy. What is clear is that surgical revascularization outperforms medical management in reducing the risk of ischemic events, and surgical revascularization probably reduces the risk of hemorrhagic events, though the latter statement is more controversial.
The risk reduction of surgical revascularization in terms of hemorrhagic strokes has been less clear. The multicenter randomized Japan Adult Moyamoya (JAM) trial has reported a beneficial effect of bilateral direct bypass in reducing rehemorrhage in patients with previous hemorrhage within the last year, with an absolute risk reduction of 19.7% at 5 years; the annual risk of hemorrhage was reduced from 7.6% per year to 2.7% per year with bilateral direct bypass (p=0.042) (18) . It should be noted that surgical risk needs to be less than 7% to see this benefit clinically (4). Patients with a history of a hemorrhagic event should be offered revascularization because of the high risk of subsequent ischemic strokes, and the JAM trial suggests that risk reduction of hemorrhage can be reduced with direct bypass if the risk of surgical complications is low. Asymptomatic patients can be offered revascularization, and it should be strongly considered if there is abnormal cerebral perfusion or high frequency of pial collateralization.
The authors prefer direct double-barrel bypass and anastomosis with both the frontal and parietal branches of the STA to the MCA cortical branches if both donor and recipient arteries are suitable. This technique provides immediate revascularization, and seems to provide the greatest risk reduction for ischemic and hemorrhagic stroke.
CONCLUSION
MD is a progressive vascular disease that affects children and adults, causing ischemic and hemorrhagic strokes. Surgical intervention can reduce the risk of neurologic sequelae, both
